Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes

Archive ouverte

Lomberk, Gwen | Blum, Yuna | Nicolle, Remy | Nair, Asha | Gaonkar, Krutika Satish | Marisa, Laetitia | Mathison, Angela | Sun, Zhifu | Yan, Huihuang | Elarouci, Nabila | Armenoult, Lucile | Ayadi, Mira | Ordog, Tamas | Lee, Jeong-Heon | Oliver, Gavin | Klee, Eric | Moutardier, Vincent | Gayet, Odile | Bian, Benjamin | Duconseil, Pauline | Gilabert, Marine | Bigonnet, Martin | Garcia, Stephane | Turrini, Olivier | Delpero, Jean-Robert | Giovannini, Marc | Grandval, Philippe | Gasmi, Mohamed | Secq, Veronique | de Reynies, Aurelien | Dusetti, Nelson | Iovanna, Juan | Urrutia, Raul

Edité par CCSD ; Nature Publishing Group -

International audience. Recent studies have offered ample insight into genome-wide expression patterns to define pancreatic ductal adenocarcinoma (PDAC) subtypes, although there remains a lack of knowledge regarding the underlying epigenomics of PDAC. Here we perform multiparametric integrative analyses of chromatin immunoprecipitation-sequencing (ChIP-seq) on multiple histone modifications, RNA-sequencing (RNA-seq), and DNA methylation to define epigenomic landscapes for PDAC subtypes, which can predict their relative aggressiveness and survival. Moreover, we describe the state of promoters, enhancers, super-enhancers, euchromatic, and heterochromatic regions for each subtype. Further analyses indicate that the distinct epigenomic landscapes are regulated by different membrane-to-nucleus pathways. Inactivation of a basal-specific super-enhancer associated pathway reveals the existence of plasticity between subtypes. Thus, our study provides new insight into the epigenetic landscapes associated with the heterogeneity of PDAC, thereby increasing our mechanistic understanding of this disease, as well as offering potential new markers and therapeutic targets.

Suggestions

Du même auteur

Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts

Archive ouverte | Nicolle, Remy | CCSD

International audience. Preclinical models based on patient-derived xenografts have remarkable specificity in distinguishing transformed human tumor cells from non-transformed murine stromal cells computationally. W...

Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts

Archive ouverte | Bian, Benjamin | CCSD

International audience. c-MYC controls more than 15% of genes responsible for proliferation , differentiation, and cellular metabolism in pancreatic as well as other cancers making this transcription factor a prime ...

Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer

Archive ouverte | Nicolle, Rémy | CCSD

International audience

Chargement des enrichissements...